| Business Summary | | IGI,
Inc.
is
a
diversified
company
engaged
in
two
business
segments:
Consumer
Products
Business,
which
involves
the
production
and
marketing
of
cosmetics
and
skin
care
products,
and
Companion
Pet
Products
Business,
which
involves
the
production
and
marketing
of
companion
pet
products
such
as
pharmaceuticals,
nutritional
supplements
and
grooming
aids.
IGI's
Consumer
Products
business
is
primarily
focused
on
the
continued
commercialization
of
its
microencapsulation
technologies
for
skin
care
applications.
IGI's
Companion
Pet
Products
Business
sells
its
pet
products
to
the
veterinarian
market
under
the
EVSCO
Pharmaceuticals
trade
name
and
to
the
over-the-counter
pet
products
market
under
the
Tomlyn
and
Luv'Em
labels. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | IGI
produces
and
markets
animal
health
products
such
as
poultry
vaccines,
veterinary
pharmaceuticals,
nutritional
supplements
and
grooming
aids.
IGI
also
produces
and
markets
consumer
cosmetics
and
skin
care
products.
For
the
three
months
ended
3/01,
revenues
fell
22
to
$4.1
million.
Net
loss
from
continuing
operations
decreased
5%
to
$779
thousand.
Revenues
reflect
lower
product
sales
for
the
Companion
Pet
Products
division.
Lower
loss
benefitted
from
cost
saving
measures. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
4,256;
after
tax
earnings
were
278. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Earl Lewis, 57 Chairman | -- | John Ambrose, 60 Pres,
Interim CEO | -- | Domenic Golato Sr.
VP, CFO | -- | Rajiv Mathur, 45 Sr.
VP and Assistant Sec. | $166K | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|